Eli Lilly diabetes drug wins FDA approval to lower cardiovascular risks - Heart disease is is the leading cause of death for ...
11hon MSN
There’s a Vaccine That Could Lower Your Risk of Heart Attack—and Most People Aren’t Getting It
This shot could help to give you a health edge in more ways than one.
Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news ...
On Aug. 28, the U.S. Food and Drug Administration (FDA) approved Mounjaro to lower the risk of heart events, including heart ...
AstraZeneca detailed the surprise failure of a closely watched heart disease trial, a study with ripple effects for a ...
Everyday Health on MSN
GLP-1 diabetes drug Mounjaro gets FDA okay to reduce heart attack and stroke
Research shows this tirzepatide GLP-1/GIP medication may help prevent cardiovascular emergencies in high-risk type 2 diabetes ...
Researchers say studying their children could help investigate the genetic and environmental factors that contribute to a ...
Gene editing reduced cholesterol by about 50% in an extremely small sample of patients over a year of follow-up, according to ...
Welltica+ on MSN
Heart doctor warns these symptoms should never be ignored
Discover the subtle, often overlooked symptoms of heart disease that a leading heart doctor warns should never be ignored.
First Horizon Corporation (NYSE: FHN) is pleased to announce that Amy Perry, Executive Vice President and Operations ...
Cytokinetics (CYTK) said Friday its drug aficamten met both primary endpoints of a Phase 3 clinical trial treating a non-obstructive heart muscle disorder. The medication improved patient-reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results